这是一篇来自已证抗体库的有关小鼠 Cd40的综述,是根据126篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Cd40 抗体。
Cd40 同义词: AI326936; Bp50; GP39; HIGM1; IGM; IMD3; T-BAM; TRAP; Tnfrsf5; p50

BioLegend
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 3a
BioLegend Cd40抗体(BioLegend, 124610)被用于被用于流式细胞仪在小鼠样本上 (图 3a). Sci Adv (2022) ncbi
大鼠 单克隆(FGK45)
  • 流式细胞仪; 小鼠; 1:200; 图 4b, s7c
BioLegend Cd40抗体(BioLegend, 157505)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 4b, s7c). J Immunother Cancer (2022) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 1:200
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上浓度为1:200. J Immunother Cancer (2021) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 3a
BioLegend Cd40抗体(Biolegend, 124621)被用于被用于流式细胞仪在小鼠样本上 (图 3a). Front Pharmacol (2021) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠
BioLegend Cd40抗体(Biolegend, 3/23)被用于被用于流式细胞仪在小鼠样本上. Int J Mol Sci (2021) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠
BioLegend Cd40抗体(Biolegend, 102902)被用于被用于流式细胞仪在小鼠样本上. Cancer Cell (2021) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠; 图 5e
BioLegend Cd40抗体(Biolegend, 102905)被用于被用于流式细胞仪在小鼠样本上 (图 5e). Mol Cancer (2021) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 5g
BioLegend Cd40抗体(Biolegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 5g). Antioxidants (Basel) (2020) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 6
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 6). Front Immunol (2020) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 1:300; 图 3o
BioLegend Cd40抗体(Biolegend, 3/23)被用于被用于流式细胞仪在小鼠样本上浓度为1:300 (图 3o). elife (2020) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 2 ug/ml; 图 3d, s5b
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上浓度为2 ug/ml (图 3d, s5b). Science (2020) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 1:100; 图 s6c, s9
BioLegend Cd40抗体(Biolegend, 124609)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 s6c, s9). Nat Commun (2020) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 1a
BioLegend Cd40抗体(Biolegend, 124610)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Front Immunol (2019) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 2h
BioLegend Cd40抗体(Biolegend, 124621)被用于被用于流式细胞仪在小鼠样本上 (图 2h). Oncoimmunology (2019) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 s15d
BioLegend Cd40抗体(Biolegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 s15d). Science (2019) ncbi
仓鼠 单克隆(HM40-3)
  • mass cytometry; 小鼠; 图 5s2b
BioLegend Cd40抗体(Bio Legend, HM40-3)被用于被用于mass cytometry在小鼠样本上 (图 5s2b). elife (2019) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 s1c
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 s1c). J Immunol (2019) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 2a
BioLegend Cd40抗体(BioLegend, 3/2.3)被用于被用于流式细胞仪在小鼠样本上 (图 2a). PLoS ONE (2018) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 1:100; 图 s9a, s9b
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 s9a, s9b). Nat Commun (2018) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 5d
BioLegend Cd40抗体(Biolegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 5d). Front Immunol (2018) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 s4a
BioLegend Cd40抗体(Biolegend, 124625)被用于被用于流式细胞仪在小鼠样本上 (图 s4a). J Clin Invest (2018) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 3a
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 3a). Front Immunol (2018) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠; 图 4a
BioLegend Cd40抗体(BioLegend, HM40-3)被用于被用于流式细胞仪在小鼠样本上 (图 4a). Front Immunol (2018) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 1:200; 图 1f
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 1f). Nat Commun (2017) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 2d
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 2d). J Immunol (2017) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 s4d
BioLegend Cd40抗体(Biolegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 s4d). Eur J Immunol (2018) ncbi
大鼠 单克隆(3/23)
BioLegend Cd40抗体(biolegend, 3/23)被用于. J Exp Med (2017) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 5a
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 5a). J Exp Med (2017) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 2b
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 2b). Immunology (2017) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 1a
BioLegend Cd40抗体(BioLegend, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Sci Rep (2016) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 6c
BioLegend Cd40抗体(BioLegend, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 6c). J Immunol (2017) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 s4e
BioLegend Cd40抗体(BioLegend, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 s4e). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(3/23)
  • 免疫组化; 小鼠; 图 s2c
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于免疫组化在小鼠样本上 (图 s2c). Diabetes (2017) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 2b
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 2b). J Immunol (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 2e
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 2e). Gastroenterology (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 4
BioLegend Cd40抗体(Biolegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 4). Aging (Albany NY) (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 1
BioLegend Cd40抗体(BioLegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 1). PLoS ONE (2015) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 7h
BioLegend Cd40抗体(Biolegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 7h). Sci Rep (2015) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 1
BioLegend Cd40抗体(Biolegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 1). Biochem Biophys Res Commun (2015) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 3
BioLegend Cd40抗体(Biolegend, clone 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 3). Eur J Immunol (2015) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 5
BioLegend Cd40抗体(Biolegend, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 5). J Heart Lung Transplant (2015) ncbi
仓鼠 单克隆(HM40-3)
  • 抑制或激活实验; 小鼠; 10 ug/ml
BioLegend Cd40抗体(BioLegend, HM40-3)被用于被用于抑制或激活实验在小鼠样本上浓度为10 ug/ml. J Immunol (2015) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 2
BioLegend Cd40抗体(BioLegend, ICI0)被用于被用于流式细胞仪在小鼠样本上 (图 2). Eur J Immunol (2015) ncbi
赛默飞世尔
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 3e
赛默飞世尔 Cd40抗体(eBioscience, 17-0401-82)被用于被用于流式细胞仪在小鼠样本上 (图 3e). Front Immunol (2022) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 5a
赛默飞世尔 Cd40抗体(eBioscience, 17-0401-81)被用于被用于流式细胞仪在小鼠样本上 (图 5a). Cell Mol Gastroenterol Hepatol (2021) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 e5c
赛默飞世尔 Cd40抗体(eBiosciences, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 e5c). Nature (2018) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 人类; 1:40; 图 4a
赛默飞世尔 Cd40抗体(eBioscience, 12-0401)被用于被用于流式细胞仪在人类样本上浓度为1:40 (图 4a). Stem Cell Res Ther (2018) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠; 图 s1b
赛默飞世尔 Cd40抗体(eBioscience, HM40)被用于被用于流式细胞仪在小鼠样本上 (图 s1b). Science (2018) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 3a
赛默飞世尔 Cd40抗体(eBioscience, 17-0401)被用于被用于流式细胞仪在小鼠样本上 (图 3a). Sci Rep (2017) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 2b
赛默飞世尔 Cd40抗体(Invitrogen, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 2b). Prostate (2017) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 s3a
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 s3a). J Clin Invest (2016) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 6e
赛默飞世尔 Cd40抗体(eBioscience, 12-0401-82)被用于被用于流式细胞仪在小鼠样本上 (图 6e). PLoS ONE (2016) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 4B
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 4B). Oncoimmunology (2016) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 1:200; 图 s7a
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 s7a). Nat Commun (2016) ncbi
大鼠 单克隆(1C10)
  • 抑制或激活实验; 小鼠; 图 7
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于抑制或激活实验在小鼠样本上 (图 7). Nat Commun (2016) ncbi
大鼠 单克隆(1C10)
  • 抑制或激活实验; 小鼠; 10,000 ug/ml; 图 2a
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于抑制或激活实验在小鼠样本上浓度为10,000 ug/ml (图 2a). J Immunol (2016) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 1:200; 图 2
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 (图 2). PLoS ONE (2015) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 4). Nature (2015) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 Cd40抗体(eBioscience, HM40-3)被用于被用于流式细胞仪在小鼠样本上 (图 3). Carbohydr Polym (2015) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 4
赛默飞世尔 Cd40抗体(eBiosciences, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 4). PLoS ONE (2014) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠
赛默飞世尔 Cd40抗体(eBioscience, HM40-3)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上. PLoS Pathog (2014) ncbi
仓鼠 单克隆(HM40-3)
  • 免疫组化-石蜡切片; 大鼠; 图 1
赛默飞世尔 Cd40抗体(eBioscience, HM40-3)被用于被用于免疫组化-石蜡切片在大鼠样本上 (图 1). Methods Mol Biol (2014) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 人类
赛默飞世尔 Cd40抗体(eBioscience, 17-0401-82)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 3). Immunol Cell Biol (2013) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上. Biomed Res Int (2013) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上. J Proteomics (2012) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 3). J Immunol (2010) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 Cd40抗体(Caltag, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 3). Am J Transplant (2009) ncbi
仓鼠 单克隆(HM40-3)
  • 抑制或激活实验; 小鼠; 1 ug/ml; 图 3
赛默飞世尔 Cd40抗体(eBioscience, HM40-3)被用于被用于抑制或激活实验在小鼠样本上浓度为1 ug/ml (图 3). Nat Immunol (2009) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 2
赛默飞世尔 Cd40抗体(Caltag, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 2). Blood (2006) ncbi
大鼠 单克隆(1C10)
  • 流式细胞仪; 小鼠; 图 5
赛默飞世尔 Cd40抗体(eBioscience, 1C10)被用于被用于流式细胞仪在小鼠样本上 (图 5). J Immunol (2005) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 1:50; 图 1
赛默飞世尔 Cd40抗体(Caltag, 3/23)被用于被用于流式细胞仪在小鼠样本上浓度为1:50 (图 1). Antivir Ther (2004) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠
赛默飞世尔 Cd40抗体(Caltag, 3/23)被用于被用于流式细胞仪在小鼠样本上. Clin Exp Immunol (2003) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠
赛默飞世尔 Cd40抗体(Caltag, 3/23)被用于被用于流式细胞仪在小鼠样本上. Gastroenterology (2000) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 表 1
赛默飞世尔 Cd40抗体(Caltag, 3/23)被用于被用于流式细胞仪在小鼠样本上 (表 1). J Immunol (2000) ncbi
Bio X Cell
大鼠 单克隆(FGK4.5/FGK45)
  • 抑制或激活实验; 小鼠; 图 5a
Bio X Cell Cd40抗体(BioXcell, FGK4.5)被用于被用于抑制或激活实验在小鼠样本上 (图 5a). PLoS ONE (2020) ncbi
大鼠 单克隆(FGK4.5/FGK45)
  • 抑制或激活实验; 小鼠; 图 5c
Bio X Cell Cd40抗体(BioXcell, FGK4.5)被用于被用于抑制或激活实验在小鼠样本上 (图 5c). elife (2020) ncbi
大鼠 单克隆(FGK4.5/FGK45)
  • 抑制或激活实验; 小鼠; 图 2f
Bio X Cell Cd40抗体(Bio X Cell, BE0016-2)被用于被用于抑制或激活实验在小鼠样本上 (图 2f). elife (2019) ncbi
大鼠 单克隆(FGK4.5/FGK45)
  • 抑制或激活实验; 小鼠; 图 2a
Bio X Cell Cd40抗体(BioXCell, FGK4.5)被用于被用于抑制或激活实验在小鼠样本上 (图 2a). Eur J Immunol (2016) ncbi
美天旎
人类 单克隆(REA965)
  • 流式细胞仪; 小鼠; 图 s4c
美天旎 Cd40抗体(Miltenyi, 130-116-037)被用于被用于流式细胞仪在小鼠样本上 (图 s4c). J Immunother Cancer (2021) ncbi
大鼠 单克隆(FGK45.5)
  • 流式细胞仪; 小鼠; 1:40; 图 1a
美天旎 Cd40抗体(Miltenyi, FGK45.5)被用于被用于流式细胞仪在小鼠样本上浓度为1:40 (图 1a). PLoS ONE (2016) ncbi
艾博抗(上海)贸易有限公司
大鼠 单克隆(44986)
  • 流式细胞仪; 小鼠; 图 2a
艾博抗(上海)贸易有限公司 Cd40抗体(Abcam, ab22469)被用于被用于流式细胞仪在小鼠样本上 (图 2a). Cell Stem Cell (2019) ncbi
小鼠 单克隆(1C10)
  • 免疫细胞化学; 小鼠; 图 2E
艾博抗(上海)贸易有限公司 Cd40抗体(Abcam, ab25298)被用于被用于免疫细胞化学在小鼠样本上 (图 2E). J Immunol (2015) ncbi
单克隆
  • 流式细胞仪; 小鼠
艾博抗(上海)贸易有限公司 Cd40抗体(Abcam, ab95535)被用于被用于流式细胞仪在小鼠样本上. J Gerontol A Biol Sci Med Sci (2014) ncbi
亚诺法生技股份有限公司
大鼠 单克隆(1C10)
  • 免疫印迹; 人类
亚诺法生技股份有限公司 Cd40抗体(Abnova, 1C10)被用于被用于免疫印迹在人类样本上. Clin Exp Immunol (2014) ncbi
碧迪BD
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 大鼠; 图 4c
碧迪BD Cd40抗体(BD Biosciences, HM 40-3)被用于被用于流式细胞仪在大鼠样本上 (图 4c). J Clin Invest (2022) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 s7c
碧迪BD Cd40抗体(BD pharmingen, 553790)被用于被用于流式细胞仪在小鼠样本上 (图 s7c). Nat Commun (2021) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 4a
碧迪BD Cd40抗体(BD Biosciences, 553788)被用于被用于流式细胞仪在小鼠样本上 (图 4a). Nat Commun (2018) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 6a
碧迪BD Cd40抗体(BD Biosciences, 553791)被用于被用于流式细胞仪在小鼠样本上 (图 6a). PLoS ONE (2017) ncbi
仓鼠 单克隆(HM40-3)
  • 抑制或激活实验; 小鼠; ; 图 9
碧迪BD Cd40抗体(BD Bioscience, 553721)被用于被用于抑制或激活实验在小鼠样本上浓度为 (图 9). Front Immunol (2017) ncbi
大鼠 单克隆(3/23)
  • 抑制或激活实验; 小鼠; 10 ug/ml; 图 5a
碧迪BD Cd40抗体(BD Biosciences, 3/23)被用于被用于抑制或激活实验在小鼠样本上浓度为10 ug/ml (图 5a). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 s2
碧迪BD Cd40抗体(BD, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 s2). Sci Rep (2016) ncbi
仓鼠 单克隆(HM40-3)
  • 抑制或激活实验; 小鼠; 5 ug/ml; 图 s2d
碧迪BD Cd40抗体(BD Biosciences, HM40-3)被用于被用于抑制或激活实验在小鼠样本上浓度为5 ug/ml (图 s2d). Proc Natl Acad Sci U S A (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 5f
碧迪BD Cd40抗体(BD, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 5f). J Exp Med (2016) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠; 图 1a
碧迪BD Cd40抗体(BD Biosciences, HM40-3)被用于被用于流式细胞仪在小鼠样本上 (图 1a). J Immunol (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 s6
碧迪BD Cd40抗体(BD Biosciences, 558695)被用于被用于流式细胞仪在小鼠样本上 (图 s6). Nat Commun (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 1d
碧迪BD Cd40抗体(BD Biosciences, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 1d). J Immunol (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 s1
碧迪BD Cd40抗体(BD Pharmingen, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 s1). J Clin Invest (2016) ncbi
仓鼠 单克隆(HM40-3)
  • 抑制或激活实验; 小鼠; 图 5a
碧迪BD Cd40抗体(BD Biosciences, HM40-3)被用于被用于抑制或激活实验在小鼠样本上 (图 5a). J Immunol (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 7a
碧迪BD Cd40抗体(Beckon Dickinson, 553791)被用于被用于流式细胞仪在小鼠样本上 (图 7a). Biol Open (2016) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠; 1:100; 图 7
碧迪BD Cd40抗体(BD Biosciences, 553723)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 7). Nat Commun (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 4a
碧迪BD Cd40抗体(Becton Dickinson, 553791)被用于被用于流式细胞仪在小鼠样本上 (图 4a). Oncoimmunology (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 s7
碧迪BD Cd40抗体(BD Pharmingen, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 s7). Cancer Immunol Immunother (2016) ncbi
仓鼠 单克隆(HM40-3)
  • 抑制或激活实验; 小鼠; 图 2b
碧迪BD Cd40抗体(BD Pharmingen, HM40-3)被用于被用于抑制或激活实验在小鼠样本上 (图 2b). PLoS ONE (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 3e
碧迪BD Cd40抗体(BD Biosciences, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 3e). J Immunol (2016) ncbi
仓鼠 单克隆(HM40-3)
  • 抑制或激活实验; 小鼠; 图 4c
碧迪BD Cd40抗体(Pharmingen, HM40-3)被用于被用于抑制或激活实验在小鼠样本上 (图 4c). Nat Genet (2016) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 1
碧迪BD Cd40抗体(BD, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 1). Sci Rep (2015) ncbi
大鼠 单克隆(3/23)
  • 免疫细胞化学; 小鼠
碧迪BD Cd40抗体(BD Pharmingen, 3/23)被用于被用于免疫细胞化学在小鼠样本上. Eur J Immunol (2015) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 表 s1
碧迪BD Cd40抗体(BD Biosciences, 3/23)被用于被用于流式细胞仪在小鼠样本上 (表 s1). Biochem Biophys Res Commun (2015) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠
  • 流式细胞仪; 人类
碧迪BD Cd40抗体(BD Pharmingen, 3/23)被用于被用于流式细胞仪在小鼠样本上 和 被用于流式细胞仪在人类样本上. Cancer Immunol Res (2015) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 大鼠; 图 10d
碧迪BD Cd40抗体(BD Biosciences, HM40-3)被用于被用于流式细胞仪在大鼠样本上 (图 10d). Brain Behav Immun (2015) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 2
碧迪BD Cd40抗体(BD Pharmingen, 553791)被用于被用于流式细胞仪在小鼠样本上 (图 2). Mol Med Rep (2015) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 s1f
碧迪BD Cd40抗体(BD Pharmingen, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 s1f). PLoS ONE (2015) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 3
碧迪BD Cd40抗体(BD Pharmingen, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 3). Nat Commun (2015) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠; 图 4
碧迪BD Cd40抗体(BD Pharmingen, 3/23)被用于被用于流式细胞仪在小鼠样本上 (图 4). PLoS ONE (2015) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠; 图 s2
碧迪BD Cd40抗体(BD Biosciences, HM40-3)被用于被用于流式细胞仪在小鼠样本上 (图 s2). Clin Sci (Lond) (2015) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠
碧迪BD Cd40抗体(BD Biosciences, 3/23)被用于被用于流式细胞仪在小鼠样本上. J Immunol (2014) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠
碧迪BD Cd40抗体(BD Biosciences, 3/23)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠
碧迪BD Cd40抗体(BD, 3/23)被用于被用于流式细胞仪在小鼠样本上. J Exp Med (2014) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠
碧迪BD Cd40抗体(BD Biosciences, HM40-3)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠
碧迪BD Cd40抗体(BD, 553790)被用于被用于流式细胞仪在小鼠样本上. Exp Mol Med (2014) ncbi
大鼠 单克隆(3/23)
  • 流式细胞仪; 小鼠
碧迪BD Cd40抗体(BD Biosciences, 3/23)被用于被用于流式细胞仪在小鼠样本上. Int Immunol (2014) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 小鼠; 1:100
碧迪BD Cd40抗体(BD Biosciences, 553723)被用于被用于流式细胞仪在小鼠样本上浓度为1:100. Nat Med (2013) ncbi
大鼠 单克隆(3/23)
  • 抑制或激活实验; 小鼠; 5 ug/ml; 图 1
碧迪BD Cd40抗体(BD Pharmingen, 553787)被用于被用于抑制或激活实验在小鼠样本上浓度为5 ug/ml (图 1). Cell Commun Signal (2011) ncbi
仓鼠 单克隆(HM40-3)
  • 流式细胞仪; 人类
碧迪BD Cd40抗体(BD Biosciences, 553723)被用于被用于流式细胞仪在人类样本上. J Immunol (2010) ncbi
文章列表
  1. Zhao F, Zhang C, Li G, Zheng H, Gu L, Zhou H, et al. A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the pathogenesis and development of psoriasis disease. Front Immunol. 2022;13:873720 pubmed 出版商
  2. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed 出版商
  3. Zhang Y, Huo F, Cao Q, Jia R, Huang Q, Wang Z, et al. FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. J Immunother Cancer. 2022;10: pubmed 出版商
  4. Besnard M, S xe9 razin C, Ossart J, Moreau A, Vimond N, Flippe L, et al. Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J Clin Invest. 2022;132: pubmed 出版商
  5. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed 出版商
  6. Zhang X, Chang A, Zou Y, Xu H, Cui J, Chen Z, et al. Aspirin Attenuates Cardiac Allograft Rejection by Inhibiting the Maturation of Dendritic Cells via the NF-κB Signaling Pathway. Front Pharmacol. 2021;12:706748 pubmed 出版商
  7. Neumann S, Campbell K, Woodall M, Evans M, Clarkson A, Young S. Obesity Has a Systemic Effect on Immune Cells in Naïve and Cancer-Bearing Mice. Int J Mol Sci. 2021;22: pubmed 出版商
  8. Hutton C, Heider F, Blanco Gómez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;: pubmed 出版商
  9. Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, et al. Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy. J Immunother Cancer. 2021;9: pubmed 出版商
  10. Nakatani T, Tsujimoto K, Park J, Jo T, Kimura T, Hayama Y, et al. The lysosomal Ragulator complex plays an essential role in leukocyte trafficking by activating myosin II. Nat Commun. 2021;12:3333 pubmed 出版商
  11. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed 出版商
  12. Go D, Lee S, Lee S, Woo S, Kim K, Kim K, et al. Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis. Cell Mol Gastroenterol Hepatol. 2021;12:715-739 pubmed 出版商
  13. Meryk A, Grasse M, Balasco L, Kapferer W, Grubeck Loebenstein B, Pangrazzi L. Antioxidants N-Acetylcysteine and Vitamin C Improve T Cell Commitment to Memory and Long-Term Maintenance of Immunological Memory in Old Mice. Antioxidants (Basel). 2020;9: pubmed 出版商
  14. Giri K, De Beaurepaire L, Jegou D, Lavy M, Mosser M, Dupont A, et al. Molecular and Functional Diversity of Distinct Subpopulations of the Stressed Insulin-Secreting Cell's Vesiculome. Front Immunol. 2020;11:1814 pubmed 出版商
  15. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed 出版商
  16. Wang R, Graham S, Sun N, McCarthy D, Peng R, Erickson J, et al. CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40. PLoS ONE. 2020;15:e0228221 pubmed 出版商
  17. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed 出版商
  18. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed 出版商
  19. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed 出版商
  20. Kodumudi K, Ramamoorthi G, Snyder C, Basu A, Jia Y, Awshah S, et al. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. Front Immunol. 2019;10:1939 pubmed 出版商
  21. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed 出版商
  22. Koike T, Harada K, Horiuchi S, Kitamura D. The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets. elife. 2019;8: pubmed 出版商
  23. Benchetrit H, Jaber M, Zayat V, Sebban S, Pushett A, Makedonski K, et al. Direct Induction of the Three Pre-implantation Blastocyst Cell Types from Fibroblasts. Cell Stem Cell. 2019;24:983-994.e7 pubmed 出版商
  24. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed 出版商
  25. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed 出版商
  26. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed 出版商
  27. Magallanes Puebla A, Espinosa Cueto P, López Marín L, Mancilla R. Mycobacterial glycolipid Di-O-acyl trehalose promotes a tolerogenic profile in dendritic cells. PLoS ONE. 2018;13:e0207202 pubmed 出版商
  28. Benmerzoug S, Rose S, Bounab B, Gosset D, Duneau L, Chenuet P, et al. STING-dependent sensing of self-DNA drives silica-induced lung inflammation. Nat Commun. 2018;9:5226 pubmed 出版商
  29. Hayashi T, Momota M, Kuroda E, Kusakabe T, Kobari S, Makisaka K, et al. DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination. Front Immunol. 2018;9:2619 pubmed 出版商
  30. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed 出版商
  31. Montero Herradón S, García Ceca J, Zapata A. Altered Maturation of Medullary TEC in EphB-Deficient Thymi Is Recovered by RANK Signaling Stimulation. Front Immunol. 2018;9:1020 pubmed 出版商
  32. Yao Y, Huang W, Li X, Li X, Qian J, Han H, et al. Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice. Front Immunol. 2018;9:965 pubmed 出版商
  33. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed 出版商
  34. Liu J, Huang X, Hao S, Wang Y, Liu M, Xu J, et al. Peli1 negatively regulates noncanonical NF-κB signaling to restrain systemic lupus erythematosus. Nat Commun. 2018;9:1136 pubmed 出版商
  35. Hong D, Ding J, Li O, He Q, Ke M, Zhu M, et al. Human-induced pluripotent stem cell-derived macrophages and their immunological function in response to tuberculosis infection. Stem Cell Res Ther. 2018;9:49 pubmed 出版商
  36. Leonardi I, Li X, Semon A, Li D, Doron I, Putzel G, et al. CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi. Science. 2018;359:232-236 pubmed 出版商
  37. Singh M, Vianden C, Cantwell M, Dai Z, Xiao Z, Sharma M, et al. Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain. Nat Commun. 2017;8:1447 pubmed 出版商
  38. Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J, et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017;199:4110-4123 pubmed 出版商
  39. Purvis H, Clarke F, Jordan C, Blanco C, Cornish G, Dai X, et al. Protein tyrosine phosphatase PTPN22 regulates IL-1β dependent Th17 responses by modulating dectin-1 signaling in mice. Eur J Immunol. 2018;48:306-315 pubmed 出版商
  40. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed 出版商
  41. Inoue T, Shinnakasu R, Ise W, Kawai C, Egawa T, Kurosaki T. The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help. J Exp Med. 2017;214:1181-1198 pubmed 出版商
  42. Kogo H, Shimizu M, Negishi Y, Uchida E, Takahashi H. Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dendritic cells by sequential administration of ?-galactosylceramide in vivo. Immunology. 2017;151:324-339 pubmed 出版商
  43. Komegae E, Souza T, Grund L, Lima C, Lopes Ferreira M. Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis. PLoS ONE. 2017;12:e0171796 pubmed 出版商
  44. Sanges S, Jendoubi M, Kavian N, Hauspie C, Speca S, Crave J, et al. B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis. Front Immunol. 2017;8:53 pubmed 出版商
  45. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed 出版商
  46. Morita K, Okamura T, Inoue M, Komai T, Teruya S, Iwasaki Y, et al. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production. Proc Natl Acad Sci U S A. 2016;113:E8131-E8140 pubmed
  47. Yokota Nakatsuma A, Ohoka Y, Takeuchi H, Song S, Iwata M. Beta 1-integrin ligation and TLR ligation enhance GM-CSF-induced ALDH1A2 expression in dendritic cells, but differentially regulate their anti-inflammatory properties. Sci Rep. 2016;6:37914 pubmed 出版商
  48. Khameneh H, Ho A, Spreafico R, Derks H, Quek H, Mortellaro A. The Syk-NFAT-IL-2 Pathway in Dendritic Cells Is Required for Optimal Sterile Immunity Elicited by Alum Adjuvants. J Immunol. 2017;198:196-204 pubmed
  49. Lund M, Greer J, Dixit A, Alvarado R, McCauley Winter P, To J, et al. A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. Sci Rep. 2016;6:37789 pubmed 出版商
  50. Sulek J, Robinson S, Petrossian A, Zhou S, Goliadze E, Manjili M, et al. Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model. Prostate. 2017;77:361-373 pubmed 出版商
  51. Wirtz T, Weber T, Kracker S, Sommermann T, Rajewsky K, Yasuda T. Mouse model for acute Epstein-Barr virus infection. Proc Natl Acad Sci U S A. 2016;113:13821-13826 pubmed
  52. Khan S, Woodruff E, Trapecar M, Fontaine K, Ezaki A, Borbet T, et al. Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med. 2016;213:2913-2929 pubmed
  53. Calmette J, Bertrand M, Vétillard M, Ellouze M, Flint S, Nicolas V, et al. Glucocorticoid-Induced Leucine Zipper Protein Controls Macropinocytosis in Dendritic Cells. J Immunol. 2016;197:4247-4256 pubmed
  54. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed 出版商
  55. Collinson Pautz M, Slawin K, Levitt J, Spencer D. MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity. PLoS ONE. 2016;11:e0164547 pubmed 出版商
  56. Klotz L, Kuzmanov I, Hucke S, Gross C, Posevitz V, Dreykluft A, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6182-E6191 pubmed
  57. Kouwenberg M, Jacobs C, van der Vlag J, Hilbrands L. Allostimulatory Effects of Dendritic Cells with Characteristic Features of a Regulatory Phenotype. PLoS ONE. 2016;11:e0159986 pubmed 出版商
  58. Zhao Y, Chu X, Chen J, Wang Y, Gao S, Jiang Y, et al. Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nat Commun. 2016;7:12368 pubmed 出版商
  59. Portillo J, Lopez Corcino Y, Miao Y, Tang J, Sheibani N, Kern T, et al. CD40 in Retinal Müller Cells Induces P2X7-Dependent Cytokine Expression in Macrophages/Microglia in Diabetic Mice and Development of Early Experimental Diabetic Retinopathy. Diabetes. 2017;66:483-493 pubmed 出版商
  60. Chow K, Delconte R, Huntington N, Tarlinton D, Sutherland R, Zhan Y, et al. Innate Allorecognition Results in Rapid Accumulation of Monocyte-Derived Dendritic Cells. J Immunol. 2016;197:2000-8 pubmed 出版商
  61. Veinotte L, Gebremeskel S, Johnston B. CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFN? production and tumor control. Oncoimmunology. 2016;5:e1160979 pubmed 出版商
  62. Rackov G, Hernandez Jimenez E, Shokri R, Carmona Rodríguez L, Manes S, Alvarez Mon M, et al. p21 mediates macrophage reprogramming through regulation of p50-p50 NF-?B and IFN-?. J Clin Invest. 2016;126:3089-103 pubmed 出版商
  63. Drake L, Iijima K, Bartemes K, Kita H. Group 2 Innate Lymphoid Cells Promote an Early Antibody Response to a Respiratory Antigen in Mice. J Immunol. 2016;197:1335-42 pubmed 出版商
  64. Lo T, Silveira P, Fromm P, Verma N, Vu P, Kupresanin F, et al. Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol. 2016;197:885-98 pubmed 出版商
  65. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed 出版商
  66. Salao K, Jiang L, Li H, Tsai V, Husaini Y, Curmi P, et al. CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis. Biol Open. 2016;5:620-30 pubmed 出版商
  67. Uto T, Fukaya T, Takagi H, Arimura K, Nakamura T, Kojima N, et al. Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity. Nat Commun. 2016;7:11273 pubmed 出版商
  68. Holmkvist P, Pool L, Hägerbrand K, Agace W, Rivollier A. IL-18R?-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness. Eur J Immunol. 2016;46:1371-82 pubmed 出版商
  69. Vandenberk L, Garg A, Verschuere T, Koks C, Belmans J, Beullens M, et al. Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma. Oncoimmunology. 2016;5:e1083669 pubmed
  70. Sim C, Cho Y, Kim B, Baek I, Kim Y, Lee M. 2'-5' Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons. Cancer Immunol Immunother. 2016;65:663-75 pubmed 出版商
  71. Gossmann J, Stolte M, Lohoff M, Yu P, Moll R, Finkernagel F, et al. A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma. PLoS ONE. 2016;11:e0150411 pubmed 出版商
  72. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed 出版商
  73. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed 出版商
  74. Levit Zerdoun E, Becker M, Pohlmeyer R, Wilhelm I, Maity P, Rajewsky K, et al. Survival of Igα-Deficient Mature B Cells Requires BAFF-R Function. J Immunol. 2016;196:2348-60 pubmed 出版商
  75. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  76. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed 出版商
  77. Schachtner H, Weimershaus M, Stache V, Plewa N, Legler D, Höpken U, et al. Loss of Gadkin Affects Dendritic Cell Migration In Vitro. PLoS ONE. 2015;10:e0143883 pubmed 出版商
  78. Onodera T, Fukuhara A, Jang M, Shin J, Aoi K, Kikuta J, et al. Adipose tissue macrophages induce PPARγ-high FOXP3(+) regulatory T cells. Sci Rep. 2015;5:16801 pubmed 出版商
  79. Fontinha D, Lopes F, Marques S, Alenquer M, Simas J. Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells. PLoS ONE. 2015;10:e0142540 pubmed 出版商
  80. Riquelme S, Pogu J, Anegon I, Bueno S, Kalergis A. Carbon monoxide impairs mitochondria-dependent endosomal maturation and antigen presentation in dendritic cells. Eur J Immunol. 2015;45:3269-88 pubmed 出版商
  81. Sun L, Sun C, Liang Z, Li H, Chen L, Luo H, et al. FSP1(+) fibroblast subpopulation is essential for the maintenance and regeneration of medullary thymic epithelial cells. Sci Rep. 2015;5:14871 pubmed 出版商
  82. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed 出版商
  83. Holtzhausen A, Zhao F, Evans K, Tsutsui M, Orabona C, Tyler D, et al. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy. Cancer Immunol Res. 2015;3:1082-95 pubmed 出版商
  84. Nacka Aleksić M, Djikić J, Pilipović I, Stojić Vukanić Z, Kosec D, Bufan B, et al. Male rats develop more severe experimental autoimmune encephalomyelitis than female rats: sexual dimorphism and diergism at the spinal cord level. Brain Behav Immun. 2015;49:101-18 pubmed 出版商
  85. Zeng S, Wang L, Li P, Wang W, Yang J. Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function. Mol Med Rep. 2015;12:2511-20 pubmed 出版商
  86. Carmi Y, Spitzer M, Linde I, Burt B, Prestwood T, Perlman N, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015;521:99-104 pubmed 出版商
  87. Kolan S, Boman A, Matozaki T, Lejon K, Oldenborg P. Lack of non-hematopoietic SIRPα signaling disturbs the splenic marginal zone architecture resulting in accumulation and displacement of marginal zone B cells. Biochem Biophys Res Commun. 2015;460:645-50 pubmed 出版商
  88. Van Den Ham K, Shio M, Rainone A, Fournier S, Krawczyk C, Olivier M. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS ONE. 2015;10:e0118451 pubmed 出版商
  89. Pone E, Lam T, Lou Z, Wang R, Chen Y, Liu D, et al. B cell Rab7 mediates induction of activation-induced cytidine deaminase expression and class-switching in T-dependent and T-independent antibody responses. J Immunol. 2015;194:3065-78 pubmed 出版商
  90. Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S, et al. TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329 pubmed 出版商
  91. Jobsri J, Allen A, Rajagopal D, Shipton M, Kanyuka K, Lomonossoff G, et al. Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody. PLoS ONE. 2015;10:e0118096 pubmed 出版商
  92. Sun H, Zhang J, Chen F, Chen X, Zhou Z, Wang H. Activation of RAW264.7 macrophages by the polysaccharide from the roots of Actinidia eriantha and its molecular mechanisms. Carbohydr Polym. 2015;121:388-402 pubmed 出版商
  93. Wirsdörfer F, Bangen J, Pastille E, Hansen W, Flohé S. Breaking the co-operation between bystander T-cells and natural killer cells prevents the development of immunosuppression after traumatic skeletal muscle injury in mice. Clin Sci (Lond). 2015;128:825-38 pubmed 出版商
  94. LUCAS B, White A, Ulvmar M, Nibbs R, Sitnik K, Agace W, et al. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur J Immunol. 2015;45:574-83 pubmed 出版商
  95. Hou J, Zhang Q, Fujino M, Cai S, Ito H, Takahashi K, et al. 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells. J Heart Lung Transplant. 2015;34:254-63 pubmed 出版商
  96. Fahl S, Harris B, Coffey F, Wiest D. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint. J Immunol. 2015;194:200-9 pubmed
  97. McDonnell A, Lesterhuis W, Khong A, Nowak A, Lake R, Currie A, et al. Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy. Eur J Immunol. 2015;45:49-59 pubmed 出版商
  98. Tassi I, Claudio E, Wang H, Tang W, Ha H, Saret S, et al. The NF-κB regulator Bcl-3 governs dendritic cell antigen presentation functions in adaptive immunity. J Immunol. 2014;193:4303-11 pubmed 出版商
  99. Chen M, Chen Y, Wu M, Yu G, Lin W, Tan T, et al. PP4 is essential for germinal center formation and class switch recombination in mice. PLoS ONE. 2014;9:e107505 pubmed 出版商
  100. Rauen J, Kreer C, Paillard A, van Duikeren S, Benckhuijsen W, Camps M, et al. Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice. PLoS ONE. 2014;9:e103755 pubmed 出版商
  101. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed 出版商
  102. Kyriakidis N, Kapsogeorgou E, Gourzi V, Konsta O, Baltatzis G, Tzioufas A. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway. Clin Exp Immunol. 2014;178:548-60 pubmed 出版商
  103. Sheng K, Herrero L, Taylor A, Hapel A, Mahalingam S. IL-3 and CSF-1 interact to promote generation of CD11c+ IL-10-producing macrophages. PLoS ONE. 2014;9:e95208 pubmed 出版商
  104. Dupont C, Christian D, Selleck E, Pepper M, Leney Greene M, Harms Pritchard G, et al. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathog. 2014;10:e1004047 pubmed 出版商
  105. Wang Y, Alexander S. DNA vaccination as a treatment for chronic kidney disease. Methods Mol Biol. 2014;1143:297-303 pubmed 出版商
  106. Hirayama T, Asano Y, Iida H, Watanabe T, Nakamura T, Goitsuka R. Meis1 is required for the maintenance of postnatal thymic epithelial cells. PLoS ONE. 2014;9:e89885 pubmed 出版商
  107. Ramakrishnan R, Tyurin V, Tuyrin V, Veglia F, Condamine T, Amoscato A, et al. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J Immunol. 2014;192:2920-31 pubmed 出版商
  108. Jin Y, Wi H, Choi M, Hong S, Bae Y. Regulation of anti-inflammatory cytokines IL-10 and TGF-? in mouse dendritic cells through treatment with Clonorchis sinensis crude antigen. Exp Mol Med. 2014;46:e74 pubmed 出版商
  109. Mercadante A, Perobelli S, Alves A, Gonçalves Silva T, Mello W, Gomes Santos A, et al. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol. 2014;192:1928-37 pubmed 出版商
  110. Tucsek Z, Toth P, Sosnowska D, Gautam T, Mitschelen M, Koller A, et al. Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2014;69:1212-26 pubmed 出版商
  111. Iwata A, Kawashima S, Kobayashi M, Okubo A, Kawashima H, Suto A, et al. Th2-type inflammation instructs inflammatory dendritic cells to induce airway hyperreactivity. Int Immunol. 2014;26:103-14 pubmed 出版商
  112. Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C, et al. Inactivation of tumor-specific CD8? CTLs by tumor-infiltrating tolerogenic dendritic cells. Immunol Cell Biol. 2013;91:545-55 pubmed 出版商
  113. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed 出版商
  114. Roehrich M, Spicher A, Milano G, Vassalli G. Characterization of cardiac-resident progenitor cells expressing high aldehyde dehydrogenase activity. Biomed Res Int. 2013;2013:503047 pubmed 出版商
  115. Ferret Bernard S, Castro Borges W, Dowle A, Sanin D, Cook P, Turner J, et al. Plasma membrane proteomes of differentially matured dendritic cells identified by LC-MS/MS combined with iTRAQ labelling. J Proteomics. 2012;75:938-48 pubmed 出版商
  116. Dufner A, Schamel W. B cell antigen receptor-induced activation of an IRAK4-dependent signaling pathway revealed by a MALT1-IRAK4 double knockout mouse model. Cell Commun Signal. 2011;9:6 pubmed 出版商
  117. Hayashi E, Granato A, Paiva L, Bertho A, Bellio M, Nobrega A. TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor. J Immunol. 2010;184:4662-72 pubmed 出版商
  118. Schuhmann M, Stegner D, Berna Erro A, Bittner S, Braun A, Kleinschnitz C, et al. Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J Immunol. 2010;184:1536-42 pubmed 出版商
  119. Iwami D, Zhang Q, Aramaki O, Nonomura K, Shirasugi N, Niimi M. Purified eicosapentaenoic acid induces prolonged survival of cardiac allografts and generates regulatory T cells. Am J Transplant. 2009;9:1294-307 pubmed 出版商
  120. Vuong B, Lee M, Kabir S, Irimia C, Macchiarulo S, McKnight G, et al. Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination. Nat Immunol. 2009;10:420-6 pubmed 出版商
  121. Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski M, et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood. 2006;107:3600-8 pubmed
  122. Hoffmann P, Kench J, Vondracek A, Kruk E, Daleke D, Jordan M, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol. 2005;174:1393-404 pubmed
  123. Freyschmidt E, Alonso A, Hartmann G, Gissmann L. Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol. Antivir Ther. 2004;9:479-89 pubmed
  124. Morin J, Faideau B, Gagnerault M, Lepault F, Boitard C, Boudaly S. Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice. Clin Exp Immunol. 2003;134:388-95 pubmed
  125. Telega G, Baumgart D, Carding S. Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased states. Gastroenterology. 2000;119:1548-59 pubmed
  126. Bauman S, Nichols K, Murphy J. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol. 2000;165:158-67 pubmed